I calculate a tangible book value of .106 with no debt covenants and 1.7m cash with a burn rate of only 200k/quarter. Shares are up to 82M now, hopefully that's where it stops, o/s.
it's going to depend on how well Altrazeal® sells worldwide, the good news is they are on the cusp of their first major revenue boost.
.11/.12 would be a primary speculative entry point, although upside may be limited to the teens until indications of medical market reception are provided.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.